• Clinical Evidence

Risk of Postoperative Hypoglycemia in Cardiovascular Surgical Patients Receiving Computer-Based Versus Paper-Based Insulin Therapy

Setting: 874-bed community teaching hospital.

Objective

This observational study compares the safety and efficacy of replacing a paper-based protocol with a computer-guided glucose management system (EndoTool) for the treatment of post-operative hyperglycemia in a cardiovascular intensive care unit.

Setting

874-bed community teaching hospital.

Results

  • Mean time spent free of clinical hypoglycemia <=70 mg/dL increased 3 days or 107.1% with EndoTool, from 2.8 to 3.8 days.
  • Incidence of clinical hypoglycemia <=70 mg/dL decreased 40.5% with EndoTool, from 31.1% to 18.5% of patients.
  • Mean time spent free of severe hypoglycemia <=40 mg/dL increased 5.9 days or 536% with EndoTool, from 1.1 to 7.0 days.
  • Incidence of severe hypoglycemia <=40 mg/dL decreased 30% with EndoTool, from 2.0% to 1.4% of patients.
  • Based on adjusted hazard ratios, patients treated using a paper-based protocol were 6 times as likely to experience clinical hypoglycemia as patients treated using EndoTool and more than 7 times as likely to experience severe hypoglycemia.

Conclusions

A computer-guided glucose management system (EndoTool) as a treatment modality facilitates attainment of appropriate glucose goals with significantly reduced incidence of hypoglycemia and improved patient safety in contrast to a paper-based protocol.

Objective

This observational study compares the safety and efficacy of replacing a paper-based protocol with a computer-guided glucose management system (EndoTool) for the treatment of post-operative hyperglycemia in a cardiovascular intensive care unit.

Setting

874-bed community teaching hospital.

Results
  • Mean time spent free of clinical hypoglycemia <=70 mg/dL increased 3 days or 107.1% with EndoTool, from 2.8 to 3.8 days.
  • Incidence of clinical hypoglycemia <=70 mg/dL decreased 40.5% with EndoTool, from 31.1% to 18.5% of patients.
  • Mean time spent free of severe hypoglycemia <=40 mg/dL increased 5.9 days or 536% with EndoTool, from 1.1 to 7.0 days.
  • Incidence of severe hypoglycemia <=40 mg/dL decreased 30% with EndoTool, from 2.0% to 1.4% of patients.
  • Based on adjusted hazard ratios, patients treated using a paper-based protocol were 6 times as likely to experience clinical hypoglycemia as patients treated using EndoTool and more than 7 times as likely to experience severe hypoglycemia.
Conclusions

A computer-guided glucose management system (EndoTool) as a treatment modality facilitates attainment of appropriate glucose goals with significantly reduced incidence of hypoglycemia and improved patient safety in contrast to a paper-based protocol.

References

Authors

Samuel Crockett, MD; Jorge Suarez-Cavelier, MD; Kevin Accola, MD; Lori Hadas, MSN; Darcey Harnage, BSN; Paul Garrett, MD; Kathy Butler, MPH; Zuber Mulla, PhD.

Source

Published in Endocrine Practice, Volume 18, Issue 4, p529-537.

Year

2012

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This observational study compares the safety and efficacy of replacing a paper-based protocol with a computer-guided glucose management system (EndoTool) for the treatment of post-operative hyperglycemia in a cardiovascular intensive care unit.

Setting

874-bed community teaching hospital.

Results
  • Mean time spent free of clinical hypoglycemia <=70 mg/dL increased 3 days or 107.1% with EndoTool, from 2.8 to 3.8 days.
  • Incidence of clinical hypoglycemia <=70 mg/dL decreased 40.5% with EndoTool, from 31.1% to 18.5% of patients.
  • Mean time spent free of severe hypoglycemia <=40 mg/dL increased 5.9 days or 536% with EndoTool, from 1.1 to 7.0 days.
  • Incidence of severe hypoglycemia <=40 mg/dL decreased 30% with EndoTool, from 2.0% to 1.4% of patients.
  • Based on adjusted hazard ratios, patients treated using a paper-based protocol were 6 times as likely to experience clinical hypoglycemia as patients treated using EndoTool and more than 7 times as likely to experience severe hypoglycemia.
Conclusions

A computer-guided glucose management system (EndoTool) as a treatment modality facilitates attainment of appropriate glucose goals with significantly reduced incidence of hypoglycemia and improved patient safety in contrast to a paper-based protocol.

References

Authors

Samuel Crockett, MD; Jorge Suarez-Cavelier, MD; Kevin Accola, MD; Lori Hadas, MSN; Darcey Harnage, BSN; Paul Garrett, MD; Kathy Butler, MPH; Zuber Mulla, PhD.

Source

Published in Endocrine Practice, Volume 18, Issue 4, p529-537.

Year

2012

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.